Back to mobile site

Analysts Remain Bullish on Dendreon (DNDN) Following Positive MEDCAC Review

November 18, 2010 3:54 PM EST Send to a Friend
Shares of Dendreon (Nasdaq: DNDN) are up more than 7% today following news from last night that the company received ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login